Aesthetic medicine products. L Catterton Asia leads Series B investment round in Nebula Brands

Derma filler

THE WHAT? Nebula Brands has announced that it has closed a US$50 million Series B funding round led by L Catterton Asia.

THE DETAIL Since its launch in May 2021,China’s leading aggregator of third-party Amazon vendors, the company has built a 50-strong team and built a solid acquisition pipeline.

Fat dissolving

 “Supported by visionary founders and an incredibly talented team, Nebula Brands has developed an efficient acquisition process and promising pipeline within a remarkably short period of time,” said L Catterton Asia Managing Partner Scott Chen. “There are significant opportunities for the company to leverage our operating capabilities, functional expertise, and global presence as we have extensive experience in its key categories. We look forward to partnering with the team to further drive Nebula Brands’ growth and market leadership.”

THE WHY? The investment will enable Nebula Brands to capitalize on the robust growth of Chinese third-party Amazon vendors. Nebula Brands Co-Founder William Wang commented, “The Chinese third-party vendor marketplace is experiencing rapid growth, with the ability to quickly scale and provide high quality products efficiently to Amazon customers across the globe. Hundreds of vendors are ready to evolve into top international brands, and we can help them reach new heights. The model of aggregating Fulfillment by Amazon vendors and strengthening their operations has already proven to be extremely effective in some markets in the west and is set to take-off in China, where Nebula Brands is leading the charge. We are excited about partnering with L Catterton, which brings deep consumer and operational expertise and a fantastic track record of value creation for portfolio companies.”

  Aesthetic medicine products. iNNBeauty Project secures minority investment from Strand Equity and Beechwood Capital

Aesthetic medicine products are developed and regulated to meet stringent safety and efficacy standards. They are typically administered by trained healthcare professionals such as dermatologists, plastic surgeons, and specialized nurses in clinical settings. These products aim to provide effective solutions for cosmetic enhancement, skin rejuvenation, and overall aesthetic improvement, contributing to both physical appearance and self-confidence.

Key categories of aesthetic medicine products include:

  • Injectables: This category includes products such as dermal fillers, botulinum toxins (e.g., Botox), and collagen stimulators. These injectables are used to smooth wrinkles, add volume, and improve facial contours.

  • Skin Rejuvenation Treatments: Products like chemical peels, microdermabrasion systems, and laser devices are used to improve skin texture, reduce pigmentation irregularities, and enhance overall skin tone.

  • Skincare Products: These include medical-grade cleansers, moisturizers, serums, and topical treatments containing active ingredients like retinoids, antioxidants, and growth factors. They are formulated to address specific skin concerns such as acne, aging, and hyperpigmentation.

  • Hair Restoration Products: Medical treatments and products designed to promote hair growth and treat conditions such as male and female pattern baldness.

  • Body Contouring and Fat Reduction: Devices and products used for non-surgical body sculpting, such as cryolipolysis (cool sculpting) devices and injectable lipolytics.

  • Cosmeceuticals: High-performance skincare products that bridge the gap between cosmetics and pharmaceuticals, often containing potent ingredients with proven clinical benefits.

  • Wound Care and Scar Management: Products like silicone sheets, gels, and advanced wound dressings used to improve healing and reduce the appearance of scars.